PubMed:33044019 / 1018-1238
Annnotations
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T5 | 46-58 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
T6 | 60-62 | Chemical | denotes | AZ | http://purl.obolibrary.org/obo/CHEBI_2955 |
T7 | 64-69 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T8 | 158-160 | Chemical | denotes | AZ | http://purl.obolibrary.org/obo/CHEBI_2955 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
63 | 42-45 | Chemical | denotes | HCQ | MESH:D006886 |
64 | 46-58 | Chemical | denotes | azithromycin | MESH:D017963 |
65 | 60-62 | Chemical | denotes | AZ | |
66 | 85-94 | Disease | denotes | mortality | MESH:D003643 |
67 | 153-156 | Chemical | denotes | HCQ | MESH:D006886 |
68 | 158-160 | Chemical | denotes | AZ |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T14 | 0-220 | Sentence | denotes | Although statistically insignificant, the HCQ/azithromycin (AZ) group had an overall mortality rate of 14.6% (n=199) compared with propensity matched no HCQ/+AZ cohort's rate of 12.1% (n=199) (OR 1.24; 95% CI 0.70-2.22). |